Skip to content
2000
Volume 15, Issue 2
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

The interest in Cannabis sativa L. phytocomplex as a medicinal tool is a recently-emerging topic. Neurodegenerative diseases represent a promising field of application for cannabis and its preparations, as most of this pathologic conditions relies on an inflammatory etiology. Several cannabis constituents display anti-inflammatory effects targeting multiple pathways. In this review, a comprehensive overview of the available literature on C. sativa constituents activities in neuroinflammation is given. On the basis that the anti-inflammatory activity of cannabis is not attributable to only a single constituent, we discuss the possible advantages of administering the whole phytocomplex in order to fully exploit the “entourage effect” in neuroinflammatory-related conditions.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/1573407214666180703130525
2019-04-01
2025-11-08
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/1573407214666180703130525
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test